Full year revenues were up 13 percent, reaching $520.5 million in 2011. The company attributes its success to its “market-share taking strategy,” which drove an increase in revenue despite a challenging spine market in the United States. The company pioneered instrumentation for the lateral approach to the spine in a procedure called eXtreme Lateral Interbody Fusion.
Sign up for our FREE Orthopedic E-Weekly for more coverage like this sent to your inbox!
Related Articles on Spine Devices:
SI-BONE Receives Patent for Broad Method Claims
Amedica Launches New Spinal Fusion Device
19 Spine Devices Receive FDA 510(k) Clearance in January
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.